Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 6NIH 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 2Gynecologic 1

Conditions

Neoplasms 172Breast Neoplasms 102Prostatic Neoplasms 45Lung Neoplasms 42Lymphoma 37Leukemia 35Brain Neoplasms 35Melanoma 29Ovarian Neoplasms 24Lymphoma, Non-Hodgkin 20Stomach Neoplasms 18HIV Infections 17Colonic Neoplasms 17Esophageal Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Urinary Bladder Neoplasms 15Glioma 15Acquired Immunodeficiency Syndrome 15Sarcoma, Kaposi 14Neoplasm Metastasis 14Leukemia, Myeloid, Acute 14Thyroid Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Kidney Neoplasms 13Hematologic Neoplasms 13Endometrial Neoplasms 13Colorectal Neoplasms 13Uterine Cervical Neoplasms 12Sarcoma 12Neurofibromatosis 1 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Observational × Risk Reduction Behavior × Clear all
NCT00040222 2026-06-01

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

National Institutes of Health Clinical Center (CC)

Completed
377 enrolled
BreastGynecologic

Breast Cancer, Familial, Breast Neoplasms, Hamartoma Syndrome, Multiple, Ovarian Neoplasms, Peutz-Jeghers Syndrome, Li-Fraumeni Syndrome, Risk Reduction Behavior

NCT02317367 2021-08-30

Self-Affirmation: Construct Validity

National Institutes of Health Clinical Center (CC)

Completed
3,112 enrolled
Breast

Alcohol Drinking, Breast Neoplasms, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡